Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
5,109.38
4,022.16
3,805.00
4,371.80
5,358.27
5,145.06
4,580.81
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,109.38
4,022.16
3,805.00
4,371.80
5,358.27
5,145.06
4,580.81
Raw Material Cost
2,777.97
2,191.27
2,038.70
2,683.69
2,973.31
2,876.56
2,648.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
651.11
624.51
566.01
480.73
505.44
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
78.87
86.46
93.81
79.76
75.53
72.99
63.89
Selling and Distribution Expenses
1,614.78
1,498.39
1,400.61
1,223.62
1,033.67
986.05
803.41
Other Expenses
-45.25
-41.42
-48.17
-37.38
-26.61
12.91
9.78
Total Expenditure (Excl Depreciation)
4,670.21
3,986.44
3,617.42
4,093.97
4,321.89
4,064.75
3,613.38
Operating Profit (PBDIT) excl Other Income
439.20000000000005
35.699999999999996
187.60000000000002
277.8
1036.4
1080.3
967.4
Other Income
177.40
84.98
184.39
67.34
126.72
151.55
59.82
Operating Profit (PBDIT)
912.87
374.25
592.51
553.96
1,341.18
1,375.89
1,144.59
Interest
78.87
86.46
93.81
79.76
75.53
72.99
63.89
Exceptional Items
-67.90
-857.77
-85.92
-32.13
1.39
-69.32
-60.07
Gross Profit (PBDT)
2,331.41
1,830.89
1,766.30
1,688.10
2,384.96
2,268.50
1,932.51
Depreciation
345.60
279.82
237.91
212.95
186.44
161.49
129.22
Profit Before Tax
420.38
-849.80
174.87
229.13
1,080.60
1,072.08
891.41
Tax
65.04
16.62
29.65
-31.42
149.32
195.07
191.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
385.97
-551.07
191.22
278.40
968.39
903.47
737.44
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
385.97
-551.07
191.22
278.40
968.39
903.47
737.44
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-62.35
-334.58
-64.13
-36.18
-37.00
-30.35
-43.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
323.62
-885.65
127.09
242.21
931.39
873.12
693.68
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
0.0
0.0
Reserves
8,521.87
8,275.63
8,812.04
8,535.17
8,430.50
7,499.56
6,623.95
Earnings per share (EPS)
0.32
-0.45
0.15
0.23
0.79
0.74
0.61
Diluted Earnings per share
0.32
-0.45
0.15
0.23
0.79
0.74
0.61
Operating Profit Margin (Excl OI)
7.63%
0.23%
4.47%
6.26%
19.19%
20.66%
20.86%
Gross Profit Margin
14.99%
-14.17%
10.85%
10.11%
23.65%
23.98%
22.28%
PAT Margin
7.55%
-13.7%
5.03%
6.37%
18.07%
17.56%
16.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 27.03% vs 5.71% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 136.54% vs -796.77% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 154.23% vs -29.11% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -8.79% vs -7.78% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Yifan Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
5,109.38
0
5,109.38
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,109.38
0
5,109.38
Raw Material Cost
2,777.97
0
2,777.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
651.11
0
651.11
Power Cost
0
0
0.00
Manufacturing Expenses
78.87
0
78.87
Selling and Distribution Expenses
1,614.78
0
1,614.78
Other Expenses
-45.25
0.00
-45.25
Total Expenditure (Excl Depreciation)
4,670.21
0
4,670.21
Operating Profit (PBDIT) excl Other Income
439.17
0.00
439.17
Other Income
177.40
0
177.40
Operating Profit (PBDIT)
912.87
0
912.87
Interest
78.87
0
78.87
Exceptional Items
-67.90
0
-67.90
Gross Profit (PBDT)
2,331.41
0
2,331.41
Depreciation
345.60
0
345.60
Profit Before Tax
420.38
0
420.38
Tax
65.04
0
65.04
Provisions and contingencies
0
0
0.00
Profit After Tax
385.97
0
385.97
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
385.97
0
385.97
Share in Profit of Associates
0
0
0.00
Minority Interest
-62.35
0
-62.35
Other related items
0.00
0.00
0.00
Consolidated Net Profit
323.62
0
323.62
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
8,521.87
0
8,521.87
Earnings per share (EPS)
0.32
0
0.32
Diluted Earnings per share
0.32
0
0.32
Operating Profit Margin (Excl OI)
7.63%
0%
0.00
7.63%
Gross Profit Margin
14.99%
0%
0.00
14.99%
PAT Margin
7.55%
0%
0.00
7.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 510.94 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 27.03% vs 5.71% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 32.36 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 136.54% vs -796.77% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 73.55 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 154.23% vs -29.11% in Dec 2023
Annual - Interest
Interest 7.89 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -8.79% vs -7.78% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.63%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






